AU2010901601A0 - Compound for the treatment of respiratory condition or disease - Google Patents
Compound for the treatment of respiratory condition or diseaseInfo
- Publication number
- AU2010901601A0 AU2010901601A0 AU2010901601A AU2010901601A AU2010901601A0 AU 2010901601 A0 AU2010901601 A0 AU 2010901601A0 AU 2010901601 A AU2010901601 A AU 2010901601A AU 2010901601 A AU2010901601 A AU 2010901601A AU 2010901601 A0 AU2010901601 A0 AU 2010901601A0
- Authority
- AU
- Australia
- Prior art keywords
- disease
- compound
- treatment
- respiratory condition
- respiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 230000000241 respiratory Effects 0.000 title 1
Priority Applications (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020127029232A KR20130106267A (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| PCT/AU2011/000434 WO2011127538A1 (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| BR112012026244A BR112012026244A2 (en) | 2010-04-15 | 2011-04-14 | use of a compound, methods for treating or alleviating the symptoms of asthma and chronic obstructive pulmonary disease, and for reducing the incidence of worsening or preventing aggravation of asthma and chronic obstructive pulmonary disease, compound and pharmaceutical combination |
| CN2011800192025A CN102844032A (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| JP2013504064A JP6148618B2 (en) | 2010-04-15 | 2011-04-14 | Compounds for the treatment of respiratory conditions or diseases |
| EP11768285.6A EP2558097B1 (en) | 2010-04-15 | 2011-04-14 | Vapendavir for the alleviation of symptoms of asthma in a subject having a HRV infection |
| AU2011241478A AU2011241478B2 (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| SG10201502391WA SG10201502391WA (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| ES11768285.6T ES2647223T3 (en) | 2010-04-15 | 2011-04-14 | Vapendavir for the relief of asthma symptoms in a subject who has a VRH infection |
| CN201510982692.9A CN105560245A (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| NZ60304011A NZ603040A (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| CA2796207A CA2796207A1 (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| EA201201416A EA025224B1 (en) | 2010-04-15 | 2011-04-14 | USE OF 3-ETHOXY-6-{2-[1-(6-METHYL-PYRIDAZIN-3-YL)PIPERIDIN-4-YL]ETHOXY}BENZO[d]ISOXAZOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN THE TREATMENT OR ALLEVIATION OF SYMPTOMS OF ASTHMA |
| SG2012073565A SG184430A1 (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
| MX2012011938A MX2012011938A (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease. |
| US13/087,624 US20110257192A1 (en) | 2010-04-15 | 2011-04-15 | Compound for treatment of respiratory condition or disease |
| IL222244A IL222244A0 (en) | 2010-04-15 | 2012-10-09 | Compound for treatment of respiratory condition or disease |
| ZA2012/07696A ZA201207696B (en) | 2010-04-15 | 2012-10-12 | Compound for treatment of respiratory condition or disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2010901601A0 true AU2010901601A0 (en) | 2010-04-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011140517A9 (en) | Methods for treating diseases of the lung | |
| ZA201403795B (en) | Formulations for the treatment of diabetes | |
| EP2621499A4 (en) | Methods for the treatment of allergic diseases | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| IL221412A (en) | System for administering medicaments on the basis of urine values | |
| GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
| IL230635A (en) | 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | |
| EP2654745A4 (en) | Composition for the treatment of skin conditions | |
| SG2014014724A (en) | METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS | |
| GB201002243D0 (en) | Respiratory disease treatment | |
| PL2538918T3 (en) | Citicoline for the treatment of glaucoma | |
| ZA201305970B (en) | Arylosulfonami for the treatment of cns diseases | |
| GB201002224D0 (en) | Respiratory disease treatment | |
| GB201006167D0 (en) | Compounds for the treatment of metabolic disorders | |
| GB201006166D0 (en) | Compounds for the treatment of metabolic disorders | |
| HU1000343D0 (en) | Use of kynurenic acid amide derivatives for the treatment of huntington disease | |
| ZA201207696B (en) | Compound for treatment of respiratory condition or disease | |
| HK1139050A1 (en) | Medicament for the treatment of pneumonia | |
| AU2010901601A0 (en) | Compound for the treatment of respiratory condition or disease | |
| PL2456445T3 (en) | Agent for the treatment of skin conditions | |
| GB201009094D0 (en) | Compounds for the treatment of closridium difficile-associated disease | |
| AU2010902823A0 (en) | Compound for the treatment of enteroviruses | |
| EP2575926B8 (en) | Apparatus for the treatment of the blood | |
| HK1196953A1 (en) | Formulations for the treatment of diabetes | |
| GB201019110D0 (en) | Compounds for the treatment of neoplasia |